PNC FINANCIAL SERVICES GROUP, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$816,434
+17.7%
9,114
+11.9%
0.00%0.0%
Q2 2023$693,720
+9.0%
8,148
+5.9%
0.00%0.0%
Q1 2023$636,679
+17.5%
7,694
+11.7%
0.00%0.0%
Q4 2022$541,820
+0.2%
6,889
-5.5%
0.00%0.0%
Q3 2022$541,000
+4.2%
7,290
-8.4%
0.00%0.0%
Q2 2022$519,000
-35.8%
7,957
-37.8%
0.00%0.0%
Q1 2022$809,000
+22.9%
12,802
+3.1%
0.00%0.0%
Q4 2021$658,000
-23.4%
12,415
+2.1%
0.00%0.0%
Q3 2021$859,000
+36.8%
12,159
+29.0%
0.00%0.0%
Q2 2021$628,000
-26.7%
9,427
+22.2%
0.00%0.0%
Q1 2021$857,000
-27.9%
7,717
-22.9%
0.00%0.0%
Q4 2020$1,189,000
+33.9%
10,009
-1.6%
0.00%0.0%
Q3 2020$888,000
+41.0%
10,173
+44.7%
0.00%0.0%
Q2 2020$630,000
-12.5%
7,030
-2.7%
0.00%0.0%
Q1 2020$720,000
-6.2%
7,224
+7.9%
0.00%0.0%
Q4 2019$768,000
-88.2%
6,692
-87.1%
0.00%
-85.7%
Q3 2019$6,536,000
-22.8%
51,815
-26.4%
0.01%
-12.5%
Q2 2019$8,468,000
+1242.0%
70,364
+876.1%
0.01%
+700.0%
Q1 2019$631,000
+27.0%
7,209
+44.9%
0.00%0.0%
Q4 2018$497,000
+3.5%
4,975
+19.0%
0.00%
Q3 2018$480,000
+207.7%
4,179
+142.1%
0.00%
Q2 2018$156,000
+11.4%
1,726
-9.9%
0.00%
Q1 2018$140,000
+22.8%
1,916
-2.8%
0.00%
Q4 2017$114,000
+32.6%
1,972
+2.5%
0.00%
Q3 2017$86,000
+68.6%
1,924
+50.2%
0.00%
Q2 2017$51,000
+10.9%
1,281
+11.4%
0.00%
Q1 2017$46,000
+43.8%
1,150
+43.8%
0.00%
Q4 2016$32,000
-8.6%
800
-18.8%
0.00%
Q3 2016$35,000
-5.4%
985
-20.2%
0.00%
Q2 2016$37,000
-15.9%
1,234
-1.0%
0.00%
Q1 2016$44,000
+10.0%
1,246
+0.9%
0.00%
Q4 2015$40,0000.0%1,2350.0%0.00%
Q3 2015$40,000
-21.6%
1,235
+0.8%
0.00%
Q2 2015$51,000
+4.1%
1,225
+12.4%
0.00%
Q1 2015$49,000
-38.0%
1,090
-48.8%
0.00%
Q4 2014$79,000
+92.7%
2,130
+85.2%
0.00%
Q3 2014$41,0000.0%1,1500.0%0.00%
Q2 2014$41,000
+10.8%
1,1500.0%0.00%
Q1 2014$37,000
-11.9%
1,150
+16.2%
0.00%
Q4 2013$42,000
-10.6%
990
-14.7%
0.00%
Q3 2013$47,000
+2.2%
1,161
+6.0%
0.00%
Q2 2013$46,0001,0950.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders